United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news Can DroneShield’s Adelaide R&D gamble unlock the next leg of its 392% stock rally? Find out how DroneShield’s A$13 million Adelaide R&D investment aims to strengthen its global counter-drone and electronic warfare footprint. byVenkateshOctober 7, 2025